Potention of L-carnitine supplementation on changes in ejection fraction and left ventricular dimension in case of dilatative cardiomyopathy in children

• المؤلفون الرئيسيون: Wahyu Wibowo, -, Mahrus A. Rahman, -, I Ketut Alit Utamayasa, -
• التنسيق: مقال PeerReviewed
• اللغة: English; English; English; English; English
• منشور في: Foundation for Enviromental Protection and Research 2020
• الموضوعات: R Medicine (General); RJ Pediatrics
• الوصول للمادة أونلاين: https://repository.unair.ac.id/109014/1/Potention%20of%20L-carnitine%20supplementation%20on%20changes%20in%20ejection%20fraction%20and%20left%20ventricular%20dimension%20in%20case%20of%20dilatative%20cardiomyopathy%20in%20children.pdf; https://repository.unair.ac.id/109014/2/Potention%20of%20L-carnitine%20supplementation%20on%20changes%20in%20ejection%20fraction%20and%20left%20ventricular%20dimension%20in%20case%20of%20dilatative%20cardiomyopathy%20in%20children.pdf; https://repository.unair.ac.id/109014/3/Potency%20of%20L.pdf; https://repository.unair.ac.id/109014/6/Bukti%20Korespondensi%20Potention%20of%20L.pdf; https://repository.unair.ac.id/109014/8/8.pdf; https://repository.unair.ac.id/109014/; http://www.ejobios.org/article/potention-of-l-carnitine-supplementation-on-changes-in-ejection-fraction-and-left-ventricular-7961

Background: Cardiomyopathy is a rare cardiac muscle disease with poor prognosis and high mortality. The main goal of dilated cardiomyopathy therapy is to restore and maximize cardiac function, but to date no medication has met these criteria. The use of oral L-carnitine as a dilated cardiomyopathy t...